Switzerland Tech Review
SEE OTHER BRANDS

Get your fresh news on science and technology in Switzerland

Switzerland Tech Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Switzerland Tech Review.

Press releases published on May 6, 2025

DemaTrading Powers Next-Gen Crypto ETP Rebalancing with Issuance Swiss

DemaTrading Powers Next-Gen Crypto ETP Rebalancing with Issuance Swiss

Issuance Swiss integrates DemaTrading to automate crypto ETP rebalancing, boosting scalability, compliance, and speed for fund managers. AMSTERDAM, NOORD-HOLLAND, NETHERLANDS, May 6, 2025 /⁨EINPresswire.com⁩/ -- DemaTrading, a rising force in digital …

ViewsML Expands to Asia Pacific, In-Licensing Technology from A*STAR

ViewsML Expands to Asia Pacific, In-Licensing Technology from A*STAR

ViewsML expands to Singapore with A*STAR tech licensing agreement to enhance AI-powered virtual biomarker platform VANCOUVER, BRITISH COLUMBIA, CANADA, May 6, 2025 /⁨EINPresswire.com⁩/ -- ViewsML, an innovator in AI-driven spatial biology and virtual …

Bpifrance, Influence Society et L’ADN réunissent des leaders du tourisme autour de l’IA à Paris

Bpifrance, Influence Society et L’ADN réunissent des leaders du tourisme autour de l’IA à Paris

Un événement stratégique sur l’IA et ses usages concrets dans le secteur touristique, organisé à l’occasion de l’ouverture de l’hôtel La Fondation PARIS, FRANCE, May 6, 2025 /⁨EINPresswire.com⁩/ -- À l’occasion de l’ouverture de l’hôtel La Fondation, …

CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3

CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3

-Initial CTX310™ Phase 1 clinical data demonstrates dose-dependent decreases in triglycerides (TG) and low-density lipoprotein (LDL), with peak reduction of up to 82% in TG and up to 81% in LDL, with a well-tolerated safety profile; presentation …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service